Overview

IL-2 in Refractory Autoimmune Encephalitis

Status:
Completed
Trial end date:
2019-06-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether low-dose IL-2 is effective in refractory autoimmune encephalitis.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Aldesleukin